Could This Centuries-Old Side Dish Help Your Body Get Rid of Microplastics? Here’s What Scientists Found

Could This Centuries-Old Side Dish Help Your Body Get Rid of Microplastics? Here’s What Scientists Found

Food & Wine
Food & WineApr 21, 2026

Why It Matters

If the effect translates to humans, kimchi could become an inexpensive, food‑based strategy to lower internal microplastic burdens, supporting broader public‑health and regulatory initiatives.

Key Takeaways

  • L. mesenteroides bound ~87% of nanoplastics in vitro
  • In mice, the bacterium doubled plastic particle excretion
  • Study used gut‑like conditions, showing resilience to bile salts
  • Human trials required; current evidence limited to animal models

Pulse Analysis

Microplastics have moved from an environmental nuisance to a direct human health threat, with particles detected in arteries, bones and even brain tissue. Federal agencies are responding: the HHS has earmarked $144 million for detection and removal technologies, while the EPA placed microplastics on its Contaminant Candidate List. This regulatory momentum reflects growing concern that chronic exposure may drive inflammation, metabolic disruption, and neurodegenerative risk, creating a market for solutions that can mitigate internal exposure.

Kimchi, a staple fermented cabbage dish, owes its probiotic power to a diverse community of lactic‑acid bacteria. The recent study spotlighted Leuconostoc mesenteroides CBA3656, which demonstrated an 87% binding rate for nanoplastic particles under simulated intestinal conditions, even in the presence of bile salts that typically damage bacterial membranes. In germ‑free mice, pre‑loading the gut with this strain more than doubled the amount of nanoplastics expelled in feces, suggesting a biologically active transport mechanism that could be harnessed through diet.

For investors and food manufacturers, the findings hint at a new frontier: functional fermented foods designed to act as biological filters for contaminants. However, the science remains at the pre‑clinical stage; human trials are essential to confirm efficacy, dosage, and safety. Should clinical data validate the mouse results, kimchi‑based probiotics could attract funding from both health‑tech venture capital and government grant programs aimed at reducing pollutant exposure. Meanwhile, consumers can view kimchi as a nutritious addition to their diet, but should temper expectations until rigorous human research is published.

Could This Centuries-Old Side Dish Help Your Body Get Rid of Microplastics? Here’s What Scientists Found

Comments

Want to join the conversation?

Loading comments...